ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,918.25
      0.00%
      US Tech 100
      20,572.00
      -0.19%
      Dow Jones
      42,635.20
      0.00%
      Brent Oil
      79.195
      2.95%
      Bitcoin
      94,985.04
      2.78%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Valerio Therapeutics (ALVIO) Quote

      Valerio Therapeutics

      Valerio Therapeutics (ALVIO)

      EU
      0.099
      0.00
      ( 0.00% )
      Updated: 07:39:51
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.099
      Bid
      0.1068
      Ask
      0.10
      Volume
      2,580,201
      0.099 Day's Range 0.1398
      0.065 52 Week Range 0.166
      Market Cap
      15.282M
      Previous Close
      0.099
      Open
      0.099
      Last Trade
      2000
      @
      0.099
      Last Trade Time
      07:25:03
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      67,567
      Shares Outstanding
      154,364,273
      Dividend Yield
      -
      PE Ratio
      -9.71
      Earnings Per Share (EPS)
      -0.13
      Revenue
      4.45M
      Net Profit
      -20.34M

      About Valerio Therapeutics

      Sector
      Medicinal Chems,botanicl Pds
      Industry
      Medicinal Chems,botanicl Pds
      Website
      valeriotx.com/
      Headquarters
      Paris, Paris, Fra
      Founded
      -
      Valerio Therapeutics is listed in the Medicinal Chems,botanicl Pds sector of the Euronext with ticker ALVIO. The last closing price for Valerio Therapeutics was 0.10 €. Over the last year, Valerio Therapeutics shares have traded in a share price range of 0.065 € to 0.166 €.

      Valerio Therapeutics currently has 154,364,273 shares outstanding. The market capitalization of Valerio Therapeutics is 15.28 € million. Valerio Therapeutics has a price to earnings ratio (PE ratio) of -9.71.

      Ask ADVFN Intelligence (AI)

      ALVIO Latest News

      More News

      FeaturedCannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology

      23 hours ago

      Réunion du Conseil d'administration de Valerio Therapeutics S.A. du 13 novembre 2024

      Regulatory News: Lors d’une réunion tenue le 13 novembre 2024, le Conseil d'administration de Valerio Therapeutics (“Valerio Therapeutics” or la “Société”) (Euronext Growth Paris : ALVIO) a...

      November 15 2024
      Business Wire

      Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company

      Valerio Therapeutics acquires Emglev Therapeutics, a single-domain antibody-based therapeutics company The transaction was completed on September 29, 2024, enabling the acquisition of Emglev’s...

      September 30 2024
      Business Wire

      Half-Year Liquidity Contract Statement for Valerio Therapeutics

      Regulatory News: Under the liquidity contract entered into between VALERIO THERAPEUTICS (Paris:ALVIO) and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30...

      August 05 2024
      Business Wire

      Valerio Therapeutics : compte rendu de l’assemblée générale mixte du 4 juin 2024

      Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris : ALVIO), ci-après « Valerio Therapeutics » ou « la Société », société de biotechnologie au stade clinique spécialisée dans le...

      June 05 2024
      Business Wire

      Valerio Therapeutics fait une mise à jour du développement clinique de son essai clinique de phase 1/2 VIO-01

      Le premier niveau de dose, évaluant 3 patients de l'essai VIO-01-101, a été autorisé conformément aux recommandations du Comité d'examen clinique. Aucun événement indésirable cliniquement...

      May 22 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.019324.21580928480.07970.13980.0781865040.0889782DE
      40.027839.04494382020.07120.13980.071314060.08125263DE
      120.01416.47058823530.0850.13980.07675670.0797123DE
      26-0.0014-1.394422310760.10040.13980.065824060.08752719DE
      52-0.065-39.63414634150.1640.1660.065862890.10328945DE
      156-0.174-63.73626373630.2730.3480.065814930.15086408DE
      260-0.174-63.73626373630.2730.3480.065814930.15086408DE

      ALVIO - Frequently Asked Questions (FAQ)

      What is the current Valerio Therapeutics share price?
      The current share price of Valerio Therapeutics is 0.099 €
      How many Valerio Therapeutics shares are in issue?
      Valerio Therapeutics has 154,364,273 shares in issue
      What is the market cap of Valerio Therapeutics?
      The market capitalisation of Valerio Therapeutics is EUR 15.28M
      What is the 1 year trading range for Valerio Therapeutics share price?
      Valerio Therapeutics has traded in the range of 0.065 € to 0.166 € during the past year
      What is the PE ratio of Valerio Therapeutics?
      The price to earnings ratio of Valerio Therapeutics is -9.71
      What is the cash to sales ratio of Valerio Therapeutics?
      The cash to sales ratio of Valerio Therapeutics is 44.44
      What is the reporting currency for Valerio Therapeutics?
      Valerio Therapeutics reports financial results in EUR
      What is the latest annual turnover for Valerio Therapeutics?
      The latest annual turnover of Valerio Therapeutics is EUR 4.45M
      What is the latest annual profit for Valerio Therapeutics?
      The latest annual profit of Valerio Therapeutics is EUR -20.34M
      What is the registered address of Valerio Therapeutics?
      The registered address for Valerio Therapeutics is 49 BOULEVARD DU GENERAL MARTIAL VALIN, PARIS, PARIS, 75015
      What is the Valerio Therapeutics website address?
      The website address for Valerio Therapeutics is valeriotx.com/
      Which industry sector does Valerio Therapeutics operate in?
      Valerio Therapeutics operates in the MEDICINAL CHEMS,BOTANICL PDS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MLCOTCoretech 5
      0.012 €
      (140.00%)
      		20k
      ALCYBCybergun
      0.0002 €
      (100.00%)
      		9.49M
      ALVGVEOM Group
      0.1545 €
      (25.10%)
      		189.95k
      ALAGOEPango SA
      0.1816 €
      (21.07%)
      		3.82M
      ALGBEGlobal Bioenergies
      1.454 €
      (18.21%)
      		210.73k
      BNBSTonner Drones
      0.001 €
      (-50.00%)
      		23.99k
      DBVDBV Technologies
      0.889 €
      (-22.70%)
      		3.78M
      MLCOUCourbet
      1.74 €
      (-16.35%)
      		1
      ALBDMBD Multi-Media
      0.82 €
      (-12.02%)
      		3.03k
      ALSRSSirius Media
      0.012 €
      (-11.76%)
      		608.37k
      ATOAtos SE
      0.002 €
      (0.00%)
      		1.22B
      BCPBanco Comercial Portugues SA
      0.4774 €
      (-0.54%)
      		17.91M
      ALVERVergnet
      0.0018 €
      (0.00%)
      		15.44M
      ALCYBCybergun
      0.0002 €
      (100.00%)
      		9.49M
      ALHPIHopium SA
      0.004 €
      (-4.76%)
      		5.09M

      Discussion

      View Full Feed
      Budots Budots 6 minutes ago
      $XONI announced the return of their Young Guns series, showcasing MMA’s most ambitious new prospective talent. https://finance.yahoo.com/news/xtreme-fighting-championships-relaunches-young-142700259.html
      XONI
      Zadie420 Zadie420 6 minutes ago
      The key word here is this "heavily Involved" in developing brain tumor vaccines.
      NWBO
      Monksdream Monksdream 7 minutes ago
      Top 15 at 7:45
      More biomed
      https://ih.advfn.com/markets/nasdaq/premarket
      Polymer Paul Polymer Paul 7 minutes ago
      Lebby left oled before they became ubiquitous... He's left lightwave before he goes to jail !!! Lol
      LWLG
      sortagreen sortagreen 7 minutes ago
      Beside the Fukushima and Chernobyl disasters, you can add the India Point and Three Mile Island near disasters. I think there was one in Great Britain early on, and if one is avoided in Zaporizhzhia, it will surely be a miracle.

      That said, and I'm not an expert on the subject, but I
      Smattchew Smattchew 8 minutes ago
      thank you for your unwavering commitment to a dead stock fka $bioaq
      BIOAQ
      sharkey1 sharkey1 9 minutes ago
      Doing a quick google search (generic Vyvanse shortage)
      and doing a drop down I found this

      Is generic Vyvanse being manufactured?
      Elite Pharmaceuticals (OTCQB: ELTP) has received FDA approval for its generic version of Vyvanse (Lisdexamfetamine Dimesylate) capsules in se
      ELTP
      Konaploinks Konaploinks 9 minutes ago
      P r out ! Peter speaks! Got the alert from Schwab but no story yet :()$@&)(,?!). Worthless
      IONQ
      DLucky6636 DLucky6636 10 minutes ago
      Apparently, Lebby was just bulls*ting in the last year. Contracts with tier 1 taking a little longer, this is a little beyond misleading. No wonder the company doesn't want to be associated with him anymore. He is an obvious litigation risk.

      Looking back though, I think the threat
      LWLG
      Konaploinks Konaploinks 10 minutes ago
      Thanks Ice😎🤙
      Jan 9, 2025,11:18am EST
      Updated Jan 9, 2025, 03:48pm EST

      When Nvidia CEO Jensen Huang suggested that practical quantum computing may still be 15 to 30 years away, he reignited skepticism about the technology’s readiness. This perspective has
      IONQ
      tw0122 tw0122 11 minutes ago
      Unless you were in prior to move as reached 3.50s won't hold much at $2.75.

      Waiting to see 830am eastern jobs report because market goes either way. They make it ok off to the races if not a market dump coming.

      .88 CGBS 1m floater small move again 
      CGBS
      Debunkinator Debunkinator 11 minutes ago
      That would send us straight to copper ville. $$$$ Weeeeeeeeeeeeeeeeeee🚂
      ASII
      RickNagra RickNagra 12 minutes ago
      Post was deleted.  What did it say Kip ?
      FNMA
      Konaploinks Konaploinks 14 minutes ago
      Shorty playing his game. I sure hope the SEC does a thorough investigation on all these last few days of trading. This could get very interesting and be even much bigger news soon. That will shine an even bigger light on quantum! Free advertising!
      IONQ
      s404n1tn0cc s404n1tn0cc 14 minutes ago
      Just checked used the word "Unpaid" as reference the only thing I found was "unpaid Invoices "... Not Loans or any type of collateral debt.
      See here
      https://document.epiq11.com/document/getdocumentsbydocket/?docketId=369623&projectCode=LBH&docketNumber=28637&source=DM
      LEHNQ
      CanItBThisEZ2Make CanItBThisEZ2Make 14 minutes ago
      Check out the new VOS (VOSIO) in the works ---->
      https://investorshub.advfn.com/uimage/uploads/2025/1/10/pmdbxNEW_VOS_IMAGE.png

      GO VOS
      GO SRMX(TCCI)$
      SRMX
      stervc stervc 14 minutes ago
      I ll be back, with these MGON liquidity thoughts...

      I do understand your thoughts. However, stocks with little liquidity, sometimes that's a good thing and sometimes that's a bad thing. I think it will ultimately depend upon the stock and how powerful its story that exists or grows in
      MGON
      TheRealMrPirate TheRealMrPirate 15 minutes ago
      Formerly #09072Q106 - FKA bioaq
      I'm sure McCoy got tired of answering your repetitive nothing posts like "Good Things Coming Very Very Very Soon!"
      It's not like you have anything useful to add to the conversation.
      Maybe you can take a stab at the qu
      StayHumble StayHumble 15 minutes ago
      Lots of💹HISTORIC $HIRU XPERT interest wow💹https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/historical
      HIRU
      Debunkinator Debunkinator 15 minutes ago
      Wow, if this is the next one--Holy crap--Fingers crossed🚀
      ASII
      penguin007 penguin007 17 minutes ago
      Are there any opinions one might want to share here on what should be considered better investment(s) shorter/longer term, within the Cohen Portfolio of Companies? There is a number of Companies included, and the list seems to be growing.
      ZHUD
      Investor082 Investor082 17 minutes ago
      Again, don't worry. You will get plenty of opportunity to buy at 25 cents or lower a few months after UK approval too as LP dilutes shareholders and raises the authorized share count in the second half of this year.
      NWBO
      StayHumble StayHumble 17 minutes ago
      💹Xplosive ShortFilm incoming💹$AMC Silver investments Golden💹
      AMC
      glenn1919 glenn1919 17 minutes ago
      SENS.....STEM.....MULN.........................https://stockcharts.com/h-sc/ui?s=MULN&p=W&yr=1&mn=3&dy=0&id=p96837884856
      MULN

      Your Recent History

      EU
      ALVIO
      Valerio Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads